How can UAB test 200,000 college students for COVID-19 in four weeks?

How can UAB test 200,000 college students for COVID-19 in four weeks?

The sheer scale of the GuideSafe Entry Testing initiative is staggering. Part of the multi-tool GuideSafe platform — a partnership between UAB and the Alabama Department of Public Health that has received more than $30 million in CARES Act funding from Gov. Kay Ivey — Alabama’s GuideSafe Entry Testing is the largest higher-education testing initiative in the nation. The pathology department has been running upward of 1,000 COVID-19 diagnostic tests per day for patients and staff at UAB, along with affiliate hospitals and other partners across Alabama, Netto said. With the GuideSafe initiative, the department expects to complete up to 10,000 additional tests per day, while still running the same 1,000 clinical tests per day (or more).

Should you get COVID antibody testing? And what do the results mean? UAB experts respond.

Should you get COVID antibody testing? And what do the results mean? UAB experts respond.

Have I had COVID-19?

That is one of the biggest questions in the world right now, and many people are looking to COVID-19 antibody tests for the answer. These blood tests search for the presence of antibodies against SARS-CoV-2, the virus that causes COVID-19. The tests expose a person’s blood to (inactive) pieces of SARS-CoV-2. Antibodies are highly specific; if a person’s blood contains antibodies that bind to SARS-CoV-2, that person has probably been infected sometime in the past two weeks to several months.

Leading the Charge: UAB’s vital role in Alabama’s COVID-19 pandemic response

Leading the Charge: UAB’s vital role in Alabama’s COVID-19 pandemic response

Due to UAB’s efforts in molecular testing led by Sixto Leal, M.D., UAB was among the first academic medical centers in the country to offer in-house testing by launching a laboratory-developed test in March. Leal and his team are able to test between 300 and 500 samples daily with COVID-19 RNA testing, confirming the presence of the virus in patients, with a turnaround time of less than 24 hours. This includes all inpatient admissions and health care workers, as well as all patients undergoing surgical procedures at UAB Hospital, and labor and delivery patients. A second COVID-19 RNA testing platform with less than two hours’ turnaround time is now operational as well.

Working behind the scenes: UAB pathologists play key role in fighting coronavirus pandemic

Working behind the scenes: UAB pathologists play key role in fighting coronavirus pandemic

Pathologists at the University of Alabama at Birmingham have been a crucial part of battling the COVID-19 pandemic in Alabama. Testing has been a major cause for concern worldwide ever since the pandemic began, but clinicians and researchers with UAB's Department of Pathology have been working around the clock to make testing available for as many people as possible, making sure accurate results are available in a timely manner.  

Watts Highlights UAB Pathology as Key in UAB's COVID19 Efforts

Watts Highlights UAB Pathology as Key in UAB's COVID19 Efforts

On May 6, UAB News released a story about the impact UAB has had on Alabama's response to the COVID-19 pandemic, titled "UAB commitment to state vital to COVID-19 response." In it, University President Ray Watts highlights the role of UAB Pathology in this unique situation. Due to UAB’s efforts in molecular testing led by Sixto Leal, M.D., UAB was among the first academic medical centers in the country to offer in-house testing by launching a laboratory-developed test in March. Leal and his team are currently testing between 300 and 500 samples daily with COVID-19 RNA testing, confirming the presence of the virus in patients, with a turnaround time of less than 24 hours. 

Netto Describes Department's COVID19 Experiences in The Pathologist

Netto Describes Department's COVID19 Experiences in The Pathologist

The Pathologist magazine, a pathology-themed magazine, published the second in its series of "pandemic diaries" featuring first-person stories from pathologists and laboratory medicine professionals around the globe, describing how their labs and departments have adapted to the COVID-19 pandemic. George Netto, M.D., Robert and Ruth Anderson Endowed Chair, UAB Pathology, is featured in this second installment of the series. 

ASCP Supports Widespread COVID-19 Diagnostic Testing - Dr. Gene Siegal

ASCP Supports Widespread COVID-19 Diagnostic Testing - Dr. Gene Siegal

The American Society for Clinical Pathology (ASCP) is the first and only national medical organization to call on the federal government to immediately develop and implement a widespread COVID-19 Diagnostic Testing and Support Strategy to help mitigate the Coronavirus Disease (COVID-19) pandemic and deter its spread. The plan will be used by states, healthcare systems, providers, clinical laboratories and others to address patient care needs in this crisis.

Zdenek Hel, Ph.D., Awarded Funds to Study Lung Damage in COVID-19

Zdenek Hel, Ph.D., Awarded Funds to Study Lung Damage in COVID-19

Zdenek Hel, Ph.D., Professor, Molecular and Cellular Pathology, has been awarded with a School of Medicine COVID-19 research grant. The $40,000, one-year award will allow Dr. Hel to study the development of acute respiratory distress syndrome (ARDS), a predictor of high mortality, in COVID-19 patients

Leal Awarded UAB SOM Grant for COVID19 Testing

Leal Awarded UAB SOM Grant for COVID19 Testing

Sixto Leal, M.D., Ph.D., Assistant Professor, Laboratory Medicine, and Director, Clinical Microbiology, Fungal Reference Laboratory and Mycoplasma Laboratory, was recently awarded a grant from the School of Medicine to support research into COVID19 testing. Leal has been working since the outset of the pandemic to convert his labs into a COVID19 testing location.
COVID-19 Related Research Flourishing in Pathology

COVID-19 Related Research Flourishing in Pathology

The Department of Pathology is excited to highlight the work of several of our faculty who are conducting or planning clinical and translational research projects related to SARS-CoV2(summarized below). Please keep us informed on any interests your lab may have in this area. Importantly, prior to initiating any work please ensure your lab is compliant with occupational health requirements and studies have necessary IRB/IACUC approvals.